Chenxin Xu
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
6-Methoxydihydrosanguinarine synergizes with cisplatin to enhance lung cancer cell death via ROS-mediated autophagy, ER stress, and JNK activation.
Journal: European journal of pharmacology
Published: August 25, 2025
Synergistic Anticancer Effects of Lenvatinib and Celastrol via ROS-Mediated ER Stress and JNK Signaling in Colon Cancer Cells.
Journal: Cancer research and treatment
Published: May 12, 2025
The glutamyl-prolyl-tRNA synthetase 1 inhibitor halofuginone exerts synergistic antitumor effects with bortezomib in colon cancer cells.
Journal: Toxicology and applied pharmacology
Published: April 22, 2025
Combination of B-AP15 and HSP90 inhibitor tanespimycin induces ROS-mediated cytotoxicity in human lung cancer cells.
Journal: BMC pharmacology & toxicology
Published: April 16, 2025
Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 09, 2024
Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells.
Journal: International journal of biological sciences
Published: May 14, 2023
Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress.
Journal: Oxidative medicine and cellular longevity
Published: November 12, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026